Glossary Flashcards
ABC type
activated B cell type. A subset of diffuse large B cell lymphomas that have a non germinal center B cell pattern of gene expression. These lesions do worse than the GCB type of diffuse large B cell lymphoma with current therapies
acute
a hematopoietic (myeloid, erthyroid, megakaryocytic) or lymphoid precursor blocked at a very early (blast or promyelocyte) stage of differentiation.
ALCL
anaplastic large cell lymphoma
ALK1
anaplastic lymphoma kinase
allogenic stem cell transplantation
transfer of hematopoietic stem cells from donor after conditioning the recipient with chemotherapy or radiation. Donors are typically HLA matched. Stem cells collected by bone marrow aspiration or mobilization, which requires the administration of GF to cause spillage of markedly left shifted cells, including CD34 stem cells, into the peripheral blood
amyloid
aggregates of proteins or protein fragments of various types. Despite their unrelated nature, these tend to settle out in deposits with a beta pleated structure. Identified histologically via Congo red stain. produce apple green birefringence under polarized light.
amyloidosis
the clinical disorder produced by systemic amyloid deposition. Prominent are the effects of amyloid deposition on the glomerular filtration apparatus
Ann Arbor staging system: stage 1
neoplasm limited to single site, +/-B (constitutional) symptoms (night sweats, weight loss, fevers)
Ann Arbor staging system
stage 1-4. used clinically to gauge extent of neoplastic spread. initially conceived for hodgkins lymphoma but also used in non hodgkin lymphoma. corresponds to the TNM staging system used for solid tumors.
ATLL
adult T cell leukemia/lymphoma
atypia
cytologic or histologic abnormalities that suggest a cell is or is becoming neoplastic. Ex: the features of plasma cell atypic include bizarre enlarged nuclei, prominent nucleoli, numerous mitotic figures. typically associated with an aggressive course
autologous stem cell transplantation
process by which stem cells are collected from a patient (often with multiple myeloma or lymphoma) after mobilization and stored frozen. After patient is subjected to chemotherapy and radiation, rescued with their own stem cells
B symptoms
cytokine mediated constitutional symptoms (fever, night sweats, weight loss) associated with some lymphomas, classically Hodgkin lymphoma
basophilic
acidic substances like DNA that bind basic dyes like Wright’s stain and hematoxylin. Blue under the microscope
BCL2
anti-apoptotic protein found in mitochondria, located on chromosome 18, inappropriately expressed in follicular lymphoma, though not in physiologic germinal centers.
BCL6
a marker, like CD10, of germinal center B cell origin. functions as a transcriptional repressor.
BCR-ABL
constitutively activated in frame tyrosine kinase fusion produced by translocation t(9;22), the Philadelphia chromosome. expressed by neoplastic cells of CML
Bence Jones Protein
light chains filtered by the glomerulus into the urine
cast nephropathy
myeloma kidney caused by obstructive distal tubular aggregates of light chain casts
CD
cluster of differentiation. antigens crucial to the classification of hematopoietic neoplasms.
CD1a
a marker of T lymphoblasts
CD2
a pan-T antigen (expressed by all mature T cells)
CD3
another pan-T antigen (expressed on the surface of all mature T cells). immature T cells express CD3 in their cytoplasm
CD4
a marker of helper T cells. the receptor for HIV in T cells
CD5
another pan-T antigen. Aberrantly expressed by some mature B cell neoplasms (CLL/SLL)
CD7
pan-T antigen expressed by all mature T cells
CD8
marker of cytotoxic T cells
CD10
expressed by mature B cells of germinal center origin and neoplasms that arise from these cells (follicular/Burkitt lymphoma).
CD19
a broad spectrum pan-B cell antigen expressed by both immature and mature B cells late into B cell life (expressed by plasma cells)
CD20
a pan-B cell antigen with a more restricted range of expression during B cell life than CD19. expressed by mature B cells, but not B lymphoblasts or plasma cells
CD34
marker of immature myeloid and lymphoid cells (blasts). included within the pool of CD34+ cells are stem cells that allow hematopoietic transplantation to succeed
CD21
a marker expressed by follicular dendritic cells, which form the microarchitechtural support structures (follicular dendritic meshwork) that allows B cell follicles to aggregate. Also expressed by B cells and serves as a receptor by which EBV infects B cells.
CD56 (NCAM)
adhesion molecule expressed by neoplastic plasma cells which allows them to take up residence in bone marrow. why multiple myeloma is a marrow based disorder.
CD138 (syndecan)
adhesion molecule expressed by plasma cells, both benign and neoplastic
centroblast
proliferative B cell making up the dark zone of a reactive germinal center. in follicular lymphoma, these are the transformed component. an increase predicts a more aggressive phenotype.
centroblastic
term used to describe a common variant of diffuse large B cell lymphoma, in which the neoplastic cells share a superficial morphology similarity with a benign centroblast, with an oval nucleus and multiple small nucleoli bosun to the nuclear membrane
centrocyte
quiescent B cell predominating in the light zone of the reactive germinal center. cytologic appearance in the peripheral blood is distinctive, with prominent nuclear clefts. formally called small cleaved cells
CFU
colony forming unit. nomenclature based on properties of progenitor cells grown on solid medium.
CHOP
cyclophosphamide, doxorubicin, oncovin, prednisone. common multi agent regimen for aggressive non hodgkin lymphoma. CHOP plus Rituxan is R-CHOP
chronic
neoplasm of hematopoeitic (myeloid, erthyroid, megakaryocytic) or lymphoid cells allowed to progress through their differentiation sequence to maturity (neutrophils, lymphocytes rather than blasts)
CLL/SLL
chronic lymphocytic leukemia/small lymphocytic leukemia. one neoplasm with two different clinical manifestations. predominantly involving peripheral blood (leukemia) or forming solid masses (lymphoma). indolent CD5+ mature B cell neoplasm with a variable clinical course that reflects the underlying stat of the B cell from which it arose
clockface
nuclear chromatin condensed in a regular pattern at the nuclear periphery (as in the clock face nuclear chromatin of a plasma cell)
CML
chronic myellogenous/myeloid leukemia, aka chronic granulocytic leukemia (CGL). form of leukemia characterized by the increased and unregulated proliferation of maturing granulocytes in the bone marrow with spillage into the peripheral blood. t(9;22) that fuses BCR and ABL to generate constitutively active tyrosine kinase
cryoglobulinemia
presence of large amounts of cryoglobulins in the blood. can be associated with various diseases that result in the expansion of plasmacytic cells, which can be reactive and neoplastic
cryoglobulins
proteins (typically Igs) that can settle out (become insoluble) at low temperatures
cytogenetics
study of karyotypic anomalies in metaphase spreads of primary or cultured cells. cells are arrested in metaphase with mitotic inhibitors and stained with giesma so the DNA G banding pattern can be identified.
cytology
microscopic appearance of a single cell
dark zone
the part of the reactive germinal center containing mostly activated B cells (centroblasts) which proliferate as part of the process of antibody refinement through somatic hypermutation and class switching.
de novo
diffuse large B cell lymphomas that arise without transformation of a preceding indolent lesion
DLBCL
diffuse large B cell lymphoma
DN
double negative- lacking both CD4 & CD8. feature of T lymphoblasts
DP
double positive- expressing both CD4 & CD8. feature of somewhat more mature T lymphoblasts
EBV
epstein barr virus. infects B cells via CD21. always found in endemic Burkitt lymphoma.
extranodal
growth or origin of a lymphoma in a non nodal site (as in MALT lymphoma)